Immunology Research
Click the below button to learn more about our autoimmune disease research and clinical trials.
Learn MoreThe main purpose of this study is to measure the effect, safety and how well the body absorbs Lebrikizumab in pediatric participants 6 months to <18 years of age with moderate-to-severe atopic dermatitis (AD).
Have Atopic Dermatitis for at least 6 months if younger than 6 years old or 1 year if older than 6 years
6 months to 12 years old and weigh over 6 kilograms
12 to 18 years old and weigh less than 40 kilograms
A parent or legal guardian must be able to sign the consent document and follow to the guidelines of the study
And meet other additional conditions at the time of the first visit
Have been in a similar study with a similar drug or received a forbidden treatment within the last 2 - 8 weeks
Be pregnant or breastfeeding
Have had previous reaction to the study drug or the ointments or cremes used in this study
Have a severe or current infection that requires strong antibiotics
Have a history of or have a current disease, or type of illness that your doctor believes could affect your safety
Have an addiction to drugs or alcohol
Click the below button to learn more about our autoimmune disease research and clinical trials.
Learn MoreWith the help of research study participants, we are learning about pediatric conditions and potential new approaches to treating disease.
Learn MoreA clinical trial is a scientific study. It helps us learn if a new medicine or treatment works and how it works. Clinical trials can also be called clinical research studies. Learn more about clinical research studies and what to expect when taking part in a clinical trial.